NeuroServo
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2065 Rue Parthenais 416, Montreal, Quebe...Phone Number
(514) 536-0250Website
www.neuroservo.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NeuroServo
NeuroServo specializes in advanced electroencephalogram (EEG) technology designed to assist hospital medical staff in real-time pathology detection. Their mission is to reduce the risk of permanent brain damage by swiftly identifying abnormalities in patients, particularly in critical care settings. The company addresses key issues such as seizure confirmation, sedation monitoring, and continuous EEG monitoring, aiming to improve patient outcomes. NeuroServo's products are intended for healthcare providers dealing with altered states of consciousness and seizure-related emergencies.Explore more
NeuroServo Org Chart
MM
Neuroscientist and ML Engineer
SF
Senior Mechanical Engineer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuroServo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if NeuroServo had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when NeuroServo launches new products
Check if NeuroServo has recently received funding, and reach out quickly before it becomes old news!
NeuroServo, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if NeuroServo is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NeuroServo
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NeuroServo recently announced quarterly report
Funding: Get notified immidiatlly once NeuroServo has new funding data
Recommended Actions
Reach out to Masked Content who joined NeuroServo as Masked Content
Find 3 more new buyers
Compare Similar Companies to NeuroServo
Compare insights from companies similar to NeuroServo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeuroServo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeuroServo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeuroServo.
NeuroServo financials insights
Gather financial insights about NeuroServo, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$1.7M
NeuroServo Tech Stack
A closer look at the technologies used by NeuroServo
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Funding
New Hire
Executive Move
New Hire
Executive Move
NeuroServo News & Media
NeuroServo announced FDA 510K clearance for VEEGix, its instant-use EEG
NeuroServo. is proud to announce that its innovative instant-use EEG has received U.S. Food and Drug Administration (FDA) clearance. MONTREAL, QC, CANADA, August 26, 2024 /EINPresswire.com/ -- VEEGix is an instant-use, compact, prefrontal EEG device …NeuroServo secures $2.2M seed financing - Private Capital Journal
Nicolas Tremblay and Jérôme Arnaud founded NeuroServo secured $2.2M seed funding from Desjardins Capital, Investissement Québec, CABHI (Centre for Aging + Brain Health Innovation), and private investors.NeuroServo (instant EEG for ICU and ER) announces closing of $2.2M funding round
NeuroServo Inc., announced today the closing of a round of $2.2 million CAD that will be used to finance the commercialization of its medical innovation, an instant-use and and miniaturized EEG (electroencephalogram) device for intensive care, operating rooms and emergencies. - www.prweb.comNeuroServo Inc announced that Dr François Marquis is joining as Chief Medical Officer
NeuroServo Inc, a Montreal-based medtech startup focusing efforts on EEG for emergency situations and cerebral pathology screening announced that Dr François Marquis is joining as Chief Medical Officer. (PRWeb October 26, 2021) Read the full story at https://www.prweb.com/releases/2021/10/prweb18269316.htm
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding NeuroServo
Sign Up For FreeTo access detailed company insights
NeuroServo specializes in advanced electroencephalogram (EEG) technology designed to assist hospital medical staff in real-time pathology detection. Their mission is to reduce the risk of permanent brain damage by swiftly identifying abnormalities in patients, particularly in critical care settings. The company addresses key issues such as seizure... Read More
